At the molecular level, the HDM challenge elevated the expression of major Th2 cytokines (IL-4 and IL-13), IL-17a, and muc5ac, which are key mediators of airway hyperresponsiveness and mucus overproduction. This evidence concerns the gene IL13 and airway hyperresponsiveness.